Enovis Return on Investment 2010-2024 | ENOV
Enovis ROI - Return on Investment Historical Data | |||
---|---|---|---|
Date | TTM Net Income | LT Investments & Debt | Return on Investment |
2024-09-30 | $-0.12B | $4.66B | -2.63% |
2024-06-30 | $-0.11B | $4.62B | -2.47% |
2024-03-31 | $-0.08B | $4.63B | -1.85% |
2023-12-31 | $-0.07B | $3.89B | -1.70% |
2023-09-30 | $-0.09B | $3.84B | -2.33% |
2023-06-30 | $-0.09B | $3.85B | -3.07% |
2023-03-31 | $-0.07B | $3.73B | -3.60% |
2022-12-31 | $-0.07B | $3.49B | -2.90% |
2022-09-30 | $-0.14B | -4.33% | |
2022-06-30 | $-0.14B | -2.88% | |
2022-03-31 | $-0.16B | $6.29B | -2.46% |
2021-12-31 | $-0.06B | $6.74B | -1.02% |
2021-09-30 | $-0.14B | $6.24B | -2.28% |
2021-06-30 | $-0.06B | $5.93B | -0.99% |
2021-03-31 | $-0.05B | $5.77B | -0.91% |
2020-12-31 | $-0.07B | $5.79B | -1.15% |
2020-09-30 | $0.20B | $5.65B | 3.42% |
2020-06-30 | $0.20B | $5.62B | 3.31% |
2020-03-31 | $0.25B | $5.85B | 3.82% |
2019-12-31 | $0.20B | $5.77B | 2.91% |
2019-09-30 | $0.12B | $7.14B | 1.80% |
2019-06-30 | $0.09B | $7.34B | 1.44% |
2019-03-31 | $0.09B | $7.78B | 1.68% |
2018-12-31 | $0.15B | $4.67B | 3.20% |
2018-09-30 | $0.07B | $4.61B | 1.52% |
2018-06-30 | $0.11B | $4.61B | 2.33% |
2018-03-31 | $0.14B | $4.96B | 2.84% |
2017-12-31 | $0.14B | $4.78B | 2.88% |
2017-09-30 | $0.26B | $4.85B | 5.70% |
2017-06-30 | $0.25B | $4.70B | 5.44% |
2017-03-31 | $0.25B | $4.46B | 5.55% |
2016-12-31 | $0.24B | $4.38B | 5.22% |
2016-09-30 | $0.23B | $4.55B | 4.90% |
2016-06-30 | $0.21B | $4.56B | 4.55% |
2016-03-31 | $0.24B | $4.68B | 4.99% |
2015-12-31 | $0.27B | $4.67B | 5.60% |
2015-09-30 | $0.33B | $4.84B | 6.81% |
2015-06-30 | $0.40B | $4.81B | 8.20% |
2015-03-31 | $0.40B | $4.68B | 7.92% |
2014-12-31 | $0.41B | $4.88B | 8.20% |
2014-09-30 | $0.42B | $5.15B | 8.76% |
2014-06-30 | $0.41B | $5.46B | 8.98% |
2014-03-31 | $0.42B | $4.50B | 10.27% |
2013-12-31 | $0.41B | $4.20B | 10.51% |
2013-09-30 | $0.34B | $3.96B | 8.96% |
2013-06-30 | $0.29B | $3.82B | 7.67% |
2013-03-31 | $0.24B | $3.51B | 6.31% |
2012-12-31 | $0.14B | $3.85B | 3.64% |
2012-09-30 | $0.08B | $3.84B | 2.71% |
2012-06-30 | $0.03B | $3.76B | 1.59% |
2012-03-31 | $-0.01B | $3.92B | -0.83% |
2011-12-31 | $0.03B | $0.29B | 8.08% |
2011-09-30 | $0.05B | $0.31B | 17.15% |
2011-06-30 | $0.06B | $0.33B | 18.58% |
2011-03-31 | $0.05B | $0.31B | 15.46% |
2010-12-31 | $0.04B | $0.29B | 12.44% |
2010-09-30 | $0.03B | $0.30B | 8.81% |
2010-06-30 | $0.03B | $0.26B | 9.32% |
2010-03-31 | $0.03B | $0.27B | 10.31% |
2009-12-31 | $0.04B | $0.30B | 14.40% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.646B | $1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $11.978B | 0.00 |
Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
Axonics (AXNX) | United States | $3.602B | 1762.00 |
IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
Privia Health (PRVA) | United States | $2.736B | 228.00 |
Omnicell (OMCL) | United States | $2.263B | 74.03 |
Azenta (AZTA) | United States | $2.242B | 127.33 |
10x Genomics (TXG) | United States | $1.925B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
Schrodinger (SDGR) | United States | $1.422B | 0.00 |
Phreesia (PHR) | United States | $1.252B | 0.00 |
Standard BioTools (LAB) | United States | $0.830B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
Talkspace (TALK) | United States | $0.586B | 0.00 |
Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
Pulmonx (LUNG) | United States | $0.298B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
TruBridge (TBRG) | United States | $0.214B | 62.22 |
P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
American Well (AMWL) | United States | $0.139B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
HeartBeam (BEAT) | United States | $0.064B | 0.00 |
111 (YI) | China | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.050B | 0.00 |
Outset Medical (OM) | United States | $0.045B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
CareCloud (CCLD) | United States | $0.042B | 0.00 |
Movano (MOVE) | United States | $0.028B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |